Immix Biopharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Immix Biopharma's balance sheet done over the years? Its assets were worth $19,925,160 last year, which is more than in the previous period. 19% of Immix Biopharma’s total assets is currently financed by debt. Its liabilities reached the amount of $3,721,783, which means an increase by 113% compared compared to last year.

Debt to Assets

Immix Biopharma, Inc. (NASDAQ:IMMX): Debt to assets
2019 942944 4.58M 486.7%
2020 539597 5.27M 976.69%
2021 18192088 202.03K 1.11%
2022 14908101 1.74M 11.73%
2023 19925160 3.72M 18.68%

IMMX Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
17.50M13.43M17.64M391.08K734.01K
Short term investments
00000
Net receivables
1.17M255.70K25.72K127.43K175.74K
Inventory
00000
Other current assets
1.10M1.20M516.19K13.71K23.5K
Total current assets
19.78M14.89M18.18M532.23K933.26K
Non-current assets:
Property, Plant and Equipment
50.18K3.56K5.69K7.36K9.68K
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
87.22K6.72K-2-1-9
Total non-current assets
137.41K10.28K5.69K7.36K9.68K
Total assets
19.92M14.90M18.19M539.59K942.94K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000342.83K0
Short term debt
0050K4.1M4.1M
Total current liabilities
3.72M1.27M202.03K5.27M4.58M
Non-current liabilities:
Long term debt
00000
Deferred tax
00000
Other non-current liabilities
0475K000
Total non-current liabilities
0475K000
Total liabilities
3.72M1.74M202.03K5.27M4.58M
Data sourceData sourceData source